Related Experiment Video
Updated: Dec 25, 2025

11:10
Membrane Potential Dye Imaging of Ventromedial Hypothalamus Neurons From Adult Mice to Study Glucose Sensing
Published on: November 27, 2013
14.1K
Glucose in the hypothalamic paraventricular nucleus regulates GLP-1 release
Yue Ma1, Risheka Ratnasabapathy1, Ivan De Backer1
1Section of Endocrinology and Investigative Medicine and.
JCI Insight
|April 2, 2020
Summary
Glucokinase in the brain
Area of Science:
- Neuroscience
- Metabolism
- Endocrinology
Background:
- Glucokinase (GK) is highly expressed in the hypothalamic paraventricular nucleus (PVN).
- The precise role of GK in the PVN concerning glucose homeostasis remains largely unknown.
- Glucagon-like peptide 1 (GLP-1) is released from enteroendocrine L cells following oral glucose intake.
Purpose of the Study:
- To elucidate the role of GK within the PVN in regulating glucose homeostasis.
- To identify a central neural mechanism controlling GLP-1 release in response to oral glucose.
- To investigate the glucose-sensing capabilities of the PVN.
Main Methods:
- Investigated the effect of altering GK expression in the PVN on GLP-1 release.
- Administered glucose and non-metabolizable glucose analogs into the PVN.
- Measured GLP-1 release following oral glucose administration under varying PVN GK conditions.
Main Results:
- Increased GK expression or direct glucose administration into the PVN enhanced GLP-1 release post-oral glucose.
- Decreased GK expression or administration of non-metabolizable glucose in the PVN abolished GLP-1 release.
- Demonstrated that glucose-sensitive GK neurons in the PVN are essential for the oral glucose response and subsequent GLP-1 secretion.
Conclusions:
- Glucokinase in the hypothalamic paraventricular nucleus functions as a critical glucose sensor.
- This PVN glucose-sensing mechanism regulates systemic glucose homeostasis by modulating GLP-1 release.
- The PVN plays a pivotal role in mediating the physiological response to oral glucose intake via GK-dependent pathways.
Related Concept Videos
Hormones Regulating Blood Glucose
6.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.1K
Glucose Homeostasis: Regulation of Blood Glucose
3.6K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.0K
Glucagon-like Receptor Agonists
757
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
757
Regulation of Food Intake
2.2K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.2K
Hypoglycemia and Glucagon
725
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
725

